Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | RET |
Variant | G810C |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | RET G810C lies within the protein kinase domain of the Ret protein (UniProt.org). G810C is associated with RET inhibitor resistance in the context of RET fusions (PMID: 31988000, PMID: 33161056), but has not been biochemically characterized and therefore, its effect on Ret protein function is unknown (PubMed, Jun 2024). |
Associated Drug Resistance | Y |
Category Variants Paths |
RET mutant RET G810C |
Transcript | NM_020975.6 |
gDNA | chr10:g.43119566G>T |
cDNA | c.2428G>T |
Protein | p.G810C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001406759.1 | chr10:g.43119566G>T | c.2428G>T | p.G810C | RefSeq | GRCh38/hg38 |
NM_001406743.1 | chr10:g.43119566G>T | c.2428G>T | p.G810C | RefSeq | GRCh38/hg38 |
NM_020630.7 | chr10:g.43119566G>T | c.2428G>T | p.G810C | RefSeq | GRCh38/hg38 |
NM_020630.5 | chr10:g.43119566G>T | c.2428G>T | p.G810C | RefSeq | GRCh38/hg38 |
NM_001406744.1 | chr10:g.43119566G>T | c.2428G>T | p.G810C | RefSeq | GRCh38/hg38 |
NM_020975 | chr10:g.43119566G>T | c.2428G>T | p.G810C | RefSeq | GRCh38/hg38 |
NM_020630 | chr10:g.43119566G>T | c.2428G>T | p.G810C | RefSeq | GRCh38/hg38 |
NM_020975.6 | chr10:g.43119566G>T | c.2428G>T | p.G810C | RefSeq | GRCh38/hg38 |
NM_020975.5 | chr10:g.43119566G>T | c.2428G>T | p.G810C | RefSeq | GRCh38/hg38 |
NM_001406760.1 | chr10:g.43119566G>T | c.2428G>T | p.G810C | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
RET G810C | Advanced Solid Tumor | predicted - sensitive | TPX-0046 | Preclinical - Cell culture | Actionable | In a preclinical study, TPX-0046 treatment led to inhibition of cell proliferation in a transformed cell line expressing RET G810C in culture (J Clin Oncol 38, no. 15_suppl (May 20, 2020) 3616-3616). | detail... |
RET G810C | Advanced Solid Tumor | predicted - sensitive | APS03118 | Preclinical - Biochemical | Actionable | In a preclinical study, APS03118 inhibited the enzymatic activity of RET G810C in an in vitro assay (J Clin Oncol 40, no. 16_suppl (June 1, 2022)). | detail... |